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Abstract  
The aquaculture of Senegalese sole (Solea senegalensis) is limited by the poor  
spawning performance of the F1 generation cultured broodstock.  The present study  
compared  the  efficiency  of  two  sustained-release  delivery  systems  loaded  with  
gonadotropin-releasing hormone agonist (GnRHa) and a single GnRHa injection on the  
stimulation of oocyte maturation (OM), sex steroid hormone secretion and spawning.  
Analysis with an ELISA showed that the administered GnRHa was no longer detectable  
in the plasma 3, 7 and 14 d after administration via a single injection, microspheres and  
an implant, respectively.  All GnRHa treatments induced a transient elevation of  
testosterone (T) and 17β estradiol (E2) plasma levels after 1-3 d.  Only three spawns  
were obtained from controls on days 35, 41 and 42 of the study and ovarian biopsies  
showed abundant fully vitellogenic oocytes, but little OM.  Fish given a GnRHa  
injection spawned sporadically and fist spawn was 20 days post treatment (dpt).  In  
contrast, both GnRHa implants and microspheres stimulated OM and daily spawning  
from 4-5 dpt for a period of 28 d.  Total fecundity in the broodstock treated with  
GnRHa-delivery systems was 15-22 times greater than controls and 3-5 times greater  
than GnRHa-injected fish.  Although egg quality appeared to be high, no fertilization  
was obtained.  The results suggest that GnRHa-delivery systems are highly efficient on  
stimulating OM and spawning in Senegalese sole, presumably through the long-term  
elevation  of  pituitary  luteinizing  hormone  release,  which  in  turn  stimulated  the  
appropriate changes in ovarian steroidogenesis.  However, the effectiveness of the  
treatment was negated by possible dysfunctions  of the male  breeders  or of the  
reproductive behavior of the broodstock.  
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1. Introduction  
The Senegalese sole (Solea senegalensis) is a common flatfish in the Mediterranean  
Sea and Southern Atlantic Ocean (Imsland et al., 2003).  In the last decade, there has  
been growing interest in the aquaculture of Senegalese sole, which has become a  
priority species for diversification in some European and Mediterranean countries  
(Imsland et al., 2003; Cañavate et al., 2005).  A number of studies have reported on  
aspects of the reproduction in captivity of wild-caught Senegalese sole broodstock,  
including gonadal development, spawning performance and egg quality (Rodríguez,  
1984; Dinis, 1986; Dinis et al., 1999; Mourente and Vázquez, 1996; Anguis and  
Cañavate, 2005).  At present, advances in rearing techniques have allowed viable eggs  
to be obtained from natural spawning of wild-caught Senegalese sole (Dinis et al., 1999;  
Anguis and Cañavate, 2005). However, efforts to establish an expanding, sustainable  
and efficient aquaculture industry for Senegalese sole have been severely constrained by  
the failure of F1 cultured broodstock to reproduce (Howell et al., 2006).  Spawning in  
cultured breeders is rare, and when it occurs fecundity is low and the eggs are  
unfertilized.  This situation has prompted studies on the reproductive characteristics of  
cultured  Senegalese  sole  that  have  provided  information  on  gonad  development,  
spawning and endocrine profiles (García-Lopez et al., 2006a, 2007; Guzmán et al.,  
2008). These  studies  demonstrated  that  cultured  females  undergo  vitellogenesis  
normally, adequate levels of vitellogenin (VTG) and sex steroid hormones are present in  
the plasma and accumulation of yolk proteins into the growing oocytes takes place.  
Nevertheless, most females fail to undergo oocyte maturation (OM), ovulation and  
spawning, and most of the developing oocytes undergo apoptosis.  
Failure to complete OM and ovulation is a common reproductive dysfunction in  
cultured fish, including flatfishes (Zohar, 1988; Zohar and Mylonas, 2001).  In most  
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cases, OM, ovulation and spawning can be stimulated through hormonal treatment with  
gonadotropins or gonadotropin-releasing hormone agonists (GnRHa), either in the form  
of liquid injections or sustained-release delivery systems (Mylonas and Zohar, 2001;  
Mañanos et al., 2008; Mylonas and Zohar, 2008).  Treatment with GnRHa delivery  
systems has proven successful for the induction of multiple spawning in several  
flatfishes with asynchronous ovarian development and has both shown higher efficiency  
than a single GnRHa injection treatments and improved quality compared to naturally  
spawning females (Mañanos et al., 2008).  For example, administration of GnRHa  
implants  induced  multiple  ovulations  in  cultured  southern  flounder (Paralichthys  
lethostigma) (Berlinsky et al., 1996) and wild-caught summer flounder (Paralichthys  
dentatus) (Berlinsky et al., 1997). In the latter case, tank spawning occurred when fish  
were acclimatized in captivity for one  year (Watanabe et al., 1998). In turbot  
(Scolphtalmus maximus), treatment with GnRHa implants induced multiple ovulations  
in 100% of the treated fish compared to 50% of controls, and reduced the inter- 
ovulation  period (Mugnier  et  al., 2000). In  yellowtail  flounder (Pleuronectes 
ferrugineus), treatment with different GnRHa delivery systems increased the number of  
ovulations, fecundity and fertilization and hatching success (Larsson et al., 1997).  
Finally, a recent attempt on hormonal induction of spawning in cultured Senegalese sole  
using a GnRHa implant or multiple GnRHa injections showed that both treatments  
induced repetitive spawning, but without any fertilization (Agulleiro et al., 2006).  
Therefore, further study of the responses of cultured Senegalese sole to hormonal  
treatments  is  required  for  the  development  of  an  optimized  spawning  induction  
protocol.  
The purpose of this study was to compare the efficacy of two sustained-release  
GnRHa delivery systems to a single injection treatment on the spawning performance of  
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cultured Senegalese sole broodstock by evaluating (a) the resulting GnRHa plasma profile 
and the induced plasma 17β estradiol (E2) and testosterone (T) levels, (b) their ovarian 
response, and (c) their spawning kinetics, fecundity and egg quality.  
 
 
2. Materials and Methods  
 
2.1. Broodstock management  
Two-year old cultured Senegalese sole, obtained from natural spawns of wild  
Senegalese sole broodstock at the facilities of CIFPA “El Toruño” (Cádiz, Spain) in the  
spring of 2001, were transported to the Institute of Aquaculture of Torre la Sal (Castellon,  
Spain) in March 2003.  Fish were tagged with passive integrated transponders (PIT tags,  
AVID, UK) and sexed by using a heterologous vitellogenin ELISA for European sea bass  
(Dicentrarchus labrax) (Mañanós et al., 1994).  Sex was further confirmed during the next  
reproductive season by abdominal swelling in females and by feeling the shape of the  
testes in males.  
Fish were reared in circular fibreglass tanks (3000 l, 1 m depth, 4.15 m2) at a density of  
3-4 kg m2, without sand substrate, and exposed to the natural temperature and photoperiod  
regimes of the region.  On 2004, water temperatures increased naturally from 16.4ºC to  
22.4ºC (mean temperature of this period, 18.7±0.4ºC) from April 30th to June 21st,  
respectively, when the first and last spontaneous spawns were registered in the F1  
broodstocks maintained at the Institute of Aquaculture of Torre la Sal.  The experiment  
was initiated on April 19th and finished on May 17th, at water temperatures of 14.6ºC and  
16.6ºC, respectively (mean temperature of this period, 16.1±0.2ºC).  Tanks were covered  
with a thin shade mesh to reduce excessive light.  Dissolved oxygen was checked regularly  
and was maintained at 6.5 ± 0.3 ppm.  Tanks were supplied with flow-through seawater  
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(salinity ~37 psu) at a flow rate of 400% day-1, and were fitted with an overflow egg 
collector.  Fish were fed ad libitum 5 days a week using dry pellets (ProAqua, Spain).  
 Handling of the fish for routine management and experimentation was always done 
according to the European Union Directive for the protection of animals used for 
experimental and other scientific purposes (EEC, 1986).  All fish to be handled were 
anesthetised by immersion in 0.3 ml l-1 of 2-phenoxyethanol.  
 
 
2.2. Experimental design and hormonal treatments  
On January 2004, 84 2-year-old cultured females with a mean (± SD) body weight  
(BW) and total length (TL) of 898 ± 55 g and 37.8 ± 0.8 cm, respectively, and males of  
839 ± 48 g BW and 36.9 ± 0.5 cm TL, respectively, were distributed in four experimental  
tanks, as described above (n=18-22 fish per tank), at a male:female sex ratio of 1:1 - 1:1.2  
for acclimatization.  To determine the best time for the initiation of the hormonal  
treatments, the external signs of ovarian maturation were examined carefully during  
spring, as described by Guzmán et al. (2008).  Briefly, the ocular side of females was  
examined and classified as stage I, II or III, corresponding to a flat, swollen or highly  
swollen abdomen, respectively.  In addition, examination of the blind side classified  
females as stage A or B, depending on the absence (A) or presence (B) of an apparent  
orange coloration along the ventral side.  Thus, as the ovary developed the classification of  
the females maturational stage proceeded from I to III and from A to B.  
When the first external signs of female maturation were observed (stages II-B and III- 
 
B),  females  (n=6)  and  males  (n=6)  were  randomly  selected  for  a  more  detailed  
determination of the stage of gonadal development.  At this time, ovarian biopsies  
examined using a binocular microscope demonstrated the presence of a significant batch of  
post-vitellogenic oocytes with an oocyte diameter of ~500 µm, together with less  
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developed oocytes at earlier stages of vitellogenesis.  All males were spermiating,  
releasing sperm by abdominal pressure, and the sperm was considered to be of good  
quality, having >80% motile spermatozoa upon activation with seawater.  On the next day  
(April 19th 2004, day 0), all fish were anesthetised, weighted and sampled for blood.  
Blood was taken from the caudal vasculature using heparinized syringes and placed in  
ice-cold heparinized tubes.  Plasma was obtained by centrifugation (3000 g, 15 min., 4 ºC)  
and stored at -20 ºC for hormone analysis.  Thereafter, fish were treated as follows: (a) In  
tank 1, Control fish (CNT) were injected with a 0.9% NaCl saline solution (9 females and  
10 males); (b) in tank 2 a single GnRHa injection at a dose of 5 µg kg-1 BW (INJ-5, 6 
females and 5 males) or a single GnRHa injection at a dose of 25 µg kg-1 BW (INJ-25, 6 
females and 5 males); (c) in tank 3 a GnRHa-loaded implant at a dose of 10 µg kg-1 BW (IMP-
10, 6 females and 5 males) or 50 µg kg-1 BW (IMP-50, 6 females and 5 males); in tank 4 
GnRHa-loaded microspheres at a dose of 20 µg kg-1 BW (MIC-20, 6 females and 5 males) or 
100 µg kg-1 BW (MIC-100, 6 females and 5 males).  
For  all  hormonal  treatments,  the  agonist  [D-Ala6,  Pro9  Net]-LHRH  (Bachem,  
Switzerland) was used.  For injection, GnRHa was dissolved in 0.9% NaCl saline.  
Implants were manufactured from Ethylene-Vinyl acetate copolymer (EVAc, Elvax;  
DuPont Chemical CO., USA) as 2-mm diameter x 3-mm cylinders (Zohar et al., 1990).  
Microspheres were prepared from biodegradable poly-[fatty acid dimmer-sebasic dimmer]  
(Mylonas  et  al., 1995). All  three  GnRHa  treatments  were  applied in  the dorsal  
musculature.  The doses of GnRHa injection, implant and microsphere treatments were  
based on previous studies with other fishes, including flatfishes (Zohar and Mylonas,  
2001).  
To  determine  the  effect  of  GnRHa  treatment  on  spawning  performance,  the  
occurrence of spawning was checked daily, and the morphology and fertilization of the  
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produced eggs was examined using a binocular microscope (see further subsection).  The effect 
of the treatments on oocyte diameter frequency and plasma levels of GnRHa, E2 and T was 
determined for each fish, thus obtaining data on the effect of the low and high doses of the 
particular treatment.  At 1, 3, 7, 14, 21 and 28 days post-treatment (dpt), females were 
anesthetised, and the following procedures completed: BW and TL were recorded; stage of 
maturation classified according to external signs and a blood sample of 0.8 ml was collected.  At 
7, 14, 21 and 28 dpt ovarian biopsies were also obtained.  
 
 
2.3. Ovarian biopsies  
The ovarian biopsy obtained from each individual female was split into two sub- 
samples; one used fresh for immediate observation under the binocular microscope to  
determine oocyte diameter and morphology, and the other processed for histological  
analysis using light microscopy.  The fresh biopsy sample was placed in a Petri dish and  
the diameter of a sample of 50 oocytes determined under the binocular microscope, using  
an ocular micrometer.  Then, the sample was dispersed with a clearing solution of  
ethanol:formalin:acetic acid (6:3:1) and the oocytes classified morphologically in five  
stages (Table 1, Fig. 1): (i) primary oocytes were small (50 - 150 µm) translucent oocytes,  
(ii)  cortical  alveoli oocytes contained  vesicles forming distinct granular rings, (iii)  
vitellogenic oocytes had an opaque and uniform cytoplasm with no indication of yolk 
clarification, (iv) post-vitellogenic oocytes exhibited germinal vesicle migration and a 
granular ooplasm indicating yolk clarification, and (v) hydrated oocytes exhibited a total 
clarification and coalescence of oil drops (Table 1).  
For histological analysis, the other ovarian subsample was placed in fixative (4%  
formaldehyde, 1% gluteraldehyde), embedded in glycol methacrylate resin (Technovit  
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7100, Heraeus Kulzer, Germany) and cut into 3-µm sections, before staining with 
methylene blue/ azure II/ basic fuchsin (Bennet et al., 1976).  
 
 
2.4. Spawning performance  
Once eggs were collected, the fecundity of the fish was determined volumetrically  
and then converted to number of eggs, considering that 1 ml contains approximately  
1,000  eggs.    The  relation  between  spawning  volume  and  number  of  eggs  was  
determined  by  counting 0.5  ml  egg  samples (n=29)  from  eight  spawns  obtained  
throughout the spawning period (April 30th to June 14th), given a value of 1.033±69 eggs  
ml-1.  Spawning quality was first evaluated by separating buoyant eggs from non-buoyant  
eggs, in an adapted volumetric cylinder filled with seawater at 37 psu and the volume of  
each recorded.  Buoyant eggs were then incubated for 48 h to determine embryo  
development and hatching success.  From each spawn, a sample of 50 buoyant eggs was  
examined using a binocular microscope to determine egg diameter, morphology and  
fertilization success.  Daily relative fecundity was calculated using the weight of the  
females at the previous sampling, and total relative fecundity was calculated at the end of  
the spawning period.  
 
 
2.5. Hormonal analyses  
For steroid analysis, plasma samples were first extracted with alcohol.  Ice-cold  
methanol was added to the plasma (6:1, v/v), shaken and centrifuged (3,000 g, 15 min,  
4ºC).  The pellet was re-extracted twice with 200 µl of methanol.  Supernatants were  
pooled, dried and reconstituted in 0.1 M potassium buffer (pH 7.4).  The concentrations  
of E2 and T were quantified by ELISA, using a protocol previously validated for  
Senegalese sole plasma samples (Guzmán et al., 2008).  The sensitivities of the ELISAs,  
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calculated as Bo-2 SD (maximum binding minus twice the standard deviation), were 5.2 pg 
ml-1 and 8.8 pg ml-1, for the E2 and T ELISA, respectively.  The intra- (n=4) and inter-
assay (n=8) coefficients of variation, at 50% of binding, were 5.8% and 6.3% for the E2, and 
6.1% and 11.3% for the T ELISA.  
A specific ELISA developed recently for the GnRHa loaded in the delivery systems  
(Mylonas et al., 2007) was validated for the quantification of GnRHa in plasma samples of  
Senegalese sole.  The sensitivity of the assay, determined as the lowest detection limit (Bo  
- 2SD), was 51.3 pg ml-1, whereas the amount of GnRHa that caused 50% of binding  
(ED50) was 340 pg ml-1.  Intra-assay variability (IA), tested by measuring replicates of the  
same sample in a single ELISA plate was 3.4% (n=4).  The inter-assay variability (IE),  
tested by analyzing the same sample in different ELISAs, analyzed by different operators  
and at different days, was 5.8% (n=10).  Prior to subjecting them to the ELISA, plasma  
samples were extracted according to a protocol for extraction of small peptides (King et  
al., 1995).  Briefly, acetone:acetic acid 2N (1:1, v/v) was added to the plasma (5:1, v/v),  
vortexed, let stand for 10 min on ice and centrifuged (16,000 g, 30 min. 4ºC).  The pellet  
was re-extracted twice with acetone:acetic acid 2N.  The supernatants were pooled,  
vacuum dried and reconstituted with distilled water.  The extract was lyophilized and  
resuspended in 0.01 M sodium phosphate buffer (PBST, pH 7.4, containing 0.9% NaCl  
and 0.05% Tween-20), centrifuged (3,000 g, 15 min. 4º C) and the supernatant stored at - 
20ºC until analysis by ELISA.  
 
 
2.6. Statistical analyses  
The expression of ELISA results was performed after linearization of the sigmoid  
standard curve using the logit transformation (logit (Bi/ Bo) = ln(Bi - NSB/Bo -NSB)),  
where Bi represents the binding of each point, Bo the maximum binding and NSB the  
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non-specific binding.  The parallelism between regression curves was tested by a 
Student’s t test.  Dependence and association between variables was analyzed by simple linear 
regression and correlation index, respectively.  The Pearson product-moment was used to 
examine the significance of regressions.  
Differences in relative daily fecundity, egg buoyancy and egg size were examined using 
One-way ANOVA followed by the Student-Newman-Keuls (SNK) multiple comparison 
procedure, with significance levels of P<0.05.  Differences in plasma levels of E2, T and 
GnRHa were examined using Two-way ANOVA followed by the HolmSidak test, with 
significance levels of P<0.05.  Normality and homogeneity of variances were tested by the 
Kolmogorov-Smirnov and Bartlett methods, respectively.  Data are expressed as mean ± 
standard error of the mean (S.E.M.).  
 
 
3. Results  
 
3.1. In vivo release kinetics of the GnRHa delivery systems.  
An ELISA method was developed and validated for analysis of GnRHa plasma  
levels  in  Senegalese  sole,  using  the  agonist [D-Ala6,  Pro9-NEthylamide]-LHRH  
(GnRHa)  for  the  standard  curve  and  for  production  of  the  specific  antibodies  
(AbGnRHa).  The characteristics of sensitivity, precision, specificity and accuracy of the  
GnRHa ELISA were carefully checked.  The precision of the GnRHa ELISA was tested by  
means of the intra- and inter-assay coefficient of variations.  The specificity of the assay  
was tested by cross-reaction of the AbGnRHa with GnRHa-free plasma from Senegalese  
sole, which showed absence of immunoreaction at dilutions lower than 1/10 (Fig. 2).  The  
accuracy of the assay was tested by spike-recovery tests, checking also the parallelism  
between  the  standard  curve  and  GnRHa-free  Senegalese  sole  plasma  spiked  with  
increasing doses of GnRHa.  The calculated recovery rate was 78.0 ± 8.6 %.  
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Females treated with a GnRHa injection had detectable GnRHa plasma levels at 1 dpt, and 
at 1 and 3 dpt for the low and high dose, respectively (Fig. 3).  Females treated with a GnRHa 
implant maintained detectable and sustained plasma GnRHa levels from 1 to 14 dpt, without 
any significant differences between the low and high dose.  Females treated with GnRHa 
microspheres exhibited an initial burst of GnRHa at 1 pdt, with the levels declining 
progressively thereafter, but remaining detectable 7 dpt.  
 
 
3.2. Plasma steroid levels  
 
Control  females  had  similar  plasma  profiles  of  E2  and  T  during  the  4-week  
experimental period, with initially low levels that increased to peak concentrations at 14 d after 
the initiation of the experiment, and decreased thereafter (Fig. 4).  All GnRHa treatments 
induced significant increases of E2 and T at 1 dpt relative to Controls (P<0.05). This was 
maintained until 3 dpt for E2.  After the initial rise, the plasma E2 profile in GnRHa-
injected females resembled that of Controls, whereas both GnRHa-implant and GnRHa-
microsphere treated females showed a gradual decrease.  Also, after 7 dpt, plasma T levels in all 
GnRHa-treated groups resembled that of Controls.  
 
 
3.3. Induction of oocyte maturation and spawning  
Control females did not show clear variations in oocyte size distribution during the 4  
week experimental period, with most of the population below 650 µm in diameter,  
consisting of oocytes at various stages of vitellogenesis and maturation (Fig. 5).  Hydrated  
oocytes were only found in one female at 14 dpt and two females at 21 and 28 dpt., but  
always at low incidence (< 5% of total).  In general, females treated with GnRHa by  
injection showed a similar oocyte size distribution to Controls.  However, 4 females of the  
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low dose GnRHa injection group possessed hydrated oocytes at weeks 2 and 3 pt, 
coincident with the recorded spawning events.  
In contrast, treatment with both GnRHa implants and microspheres (high and low  
doses) caused a clear differentiation of the oocyte size distribution relative to Controls  
(Fig. 5). Beginning one week after treatment and throughout the experiment, post- 
vitellogenic and hydrated oocytes (diameter >650 µm) were present.  All females from  
these groups appeared to have spawned at least once, as evidenced by the presence of  
ovulated eggs in their biopsies and a high volume of ovarian fluid.  Daily fecundities  
decreased at 28 dpt in GnRHa-implanted females and 21 dpt in females treated with  
GnRHa-microspheres.  At this time, there were still significant numbers of hydrated  
oocytes in the biopsies, together with apoptotic oocytes that were very abundant at 28  
dpt in the fish treated with GnRHa microspheres.  Fish from the Control tank showed  
sporadic spawning of low fecundity in May and June (Fig. 6).  The GnRHa injection  
treatment caused no apparent effect on spawning, with some late spawning detected in  
May-June.  In contrast, both sustained-release GnRHa delivery systems induced spawning  
from 4 and 6 dpt, respectively.  In both cases, a clear rhythm of daily spawning was  
established until day 26-28 pt, then continuing with sporadic spawning during the next  
month presumably not under the direct influence of the GnRHa treatments.  
All three GnRHa treatments improved spawning performance with respect to Controls  
(Table 2).  All treatments increased the number of spawnings, the spawning period and  
daily fecundity, with respect to Controls.  Total fecundity was increased 4-fold by the  
GnRHa injection and 22- and 15-fold by the GnRHa implant and microsphere treatments,  
respectively, with respect to Controls.  Egg buoyancy was similar in GnRHa treated fish,  
but all eggs were unfertilized, based on the absence of embryos 24 h after spawning.  No  
differences in mean egg diameter were found among treatments (Table 2).  However, a  
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significant decrease in egg size was observed in the GnRHa implanted fish along the 
spawning period (P <0.01, Fig. 7).  This correlation between decreasing egg size and the date 
of spawning became highly significant when considering the first 4 weeks after treatment, 
the period of induced spawning under direct GnRHa influence, were the fish treated with 
GnRHa microspheres also exhibited a significant reduction of egg size with time.  There were 
no significant changes in egg diameter during the experiment in spawns from the Control or 
GnRHa-injected tanks.  
 
 
4. Discussion  
Currently, the emerging aquaculture industry for the Senegalese sole is entirely  
dependent on the spawning of wild-caught individuals (Dinis et al., 1999; Imsland et al.,  
2003; Howell et al., 2006).  The expansion and optimization of this industry requires the  
development of protocols for the control of reproduction of cultured broodstock (F1  
generation).  The present work studied the efficacy of three GnRHa-based spawning  
induction therapies on cultured Senegalese sole, by comparing injection with two  
sustained-release delivery systems (Mylonas and Zohar, 2001). This is the first report  
on in vivo release kinetics of GnRHa treatments in a warm-water flatfish and the results  
may be applicable to related species.  The ELISA developed for this purpose showed  
optimal characteristics of precision, accuracy and specificity, and its sensitivity was  
comparable to previously developed GnRHa radioimmunoassays, which were 62 pg ml- 
1 (Sherwood et al., 1988) and 50 pg ml-1 (Mylonas et al., 1997a).  The exogenously  
administered GnRHa in Senegalese sole was cleared from the circulation at different  
rates, depending on the administration method, and was 3 d for injection, 14 d for  
microspheres and 21 d for implants.  This pharmacokinetic information is of interest in  
determining the duration of the GnRHa in vivo action and the adequate timing for  
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potential repetitive treatments  (Mylonas et al.,  2004).  However, the clearance of  
exogenous GnRHa from the blood may vary due to administration method and dose, but  
also due to water temperature and the metabolism of the species (Zohar and Mylonas,  
2001; King and Pankhurst, 2004).  For example, in winter flounder (Pleuronectes  
americanus) GnRHa given as a single injection was cleared from the circulation in 3 d  
(Harmin and Crim, 1993), whereas in common dentex (Dentex dentex) in only 24 h  
(Greenwood et al., 2001).  When administered via an implant, plasma GnRHa levels in  
Atlantic halibut (Hippoglossus hippoglossus) peaked at 6 dpt and then declined slowly  
for 1 month (Vermeirssen et al., 2000), while in common dentex peaked at 10 dpt and  
remained detectable for 24 d (Greenwood et al., 2001).  Administration of GnRHa via  
microspheres resulted in peak GnRHa plasma levels at 5 dpt in the North Sea plaice  
(Pleuronectes platessa) and remained detectable for 43 d (Vermeirssen et al., 1998),  
whereas in gilthead seabream (Sparus aurata) peaked immediately after implantation  
and became undetectable after 7 d (Mylonas and Zohar, 2001).  A higher dose for the  
microspheres was used compared to the implants, since microspheres were expected to  
result in a longer release duration compared to the implants (8 vs 4 weeks) (Mylonas et al.,  
1995).  Therefore, in order to achieve similar plasma GnRHa levels for at least the first 4  
weeks of the study, a twice as high dose was used.  However, the opposite was observed,  
with microspheres releasing for a much less period of time.  
Plasma levels of both E2 and T increased after all three GnRHa treatments,  
indicating stimulation of gonadotropin-mediated sex steroid secretion by the gonad.  
Previous studies with other fishes reported a similar sex steroid increase soon after  
GnRHa treatment.  For example, female yellowtail flounder treated with GnRHa  
implants or microspheres showed increased plasma E2 levels 4 dpt (Larsson et al.,  
1997).  In stripped trumpeter (Latris lineata), GnRHa implantation increased T and E2  
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levels at days 1 and 2, respectively (Morehead et al., 1998), whereas in captive white  
bass (Morone chrysops) both E2 and T plasma levels peaked 18 h after GnRHa  
treatment (Mylonas et al., 1997).  After the initial GnRHa induced rise of sex steroid  
secretion, the plasma levels of E2 decreased steadily in Senegalese sole treated with  
both GnRHa implants and microspheres, but remained elevated in controls and GnRHa  
injected fish.  This could be related to the observed differences in spawning between  
groups.  A study performed in the North Sea plaice (Pleuronectes platessa), showed that  
treatment with a GnRHa implant caused an initial rise of plasma T and E2 levels 4 dpt  
and a sharp decrease thereafter, which was correlated with a concomitant increase of  
plasma progestogens and the stimulation of OM (Scott et al., 1999).  In the present  
study, the decreased plasma levels of E2 in Senegalese sole treated with implants and  
microspheres could be correlated with the steroidogenic shift to the production of  
progestogens (Senthilkumaran et al., 2004), related to the observed stimulation of OM  
and spawning in these group of fish, as compared to controls and GnRHa injected  
Senegalese sole.  
Saline-treated Senegalese sole in the present study produced some spawns of poor  
quality in May and early June.  This was expected, since spawning of cultured breeders  
at our facilities coincides with the main natural spawning period of wild-caught  
Senegalese sole broodstock (Guzmán et al., 2008).  Egg production by cultured  
broodstock is always less frequent and of lower fecundity than that of wild breeders.  In the 
present study, the fecundity of the Controls was 150-fold lower than reported for wild-
caught broodstocks (Anguis and Cañavate, 2005), reflecting the fact that only one third of 
females ovulated, producing small numbers of hydrated oocytes (<5% of the total oocyte 
population).  
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In  contrast,  GnRHa  treatments  induced  significantly  more  spawning  events.  
Although  a  single  GnRHa  injection was relatively  ineffective, both  implant  and  
microspheres induced daily spawning for a period of around 3 weeks.  Injected fish  
showed a slightly higher fecundity than Controls, although this might not have been  
caused directly by the hormonal treatment, because the first spawning was observed at  
21 dpt, which was 17 d after exogenously administered GnRHa had disappeared from  
the bloodstream in these fish.  Also, the observation of the ovarian biopsies in the  
injected females did not reveal significant signs of induced maturation in the first two  
weeks following treatment, and total fecundity and number of spawns per female,  
although lower than the Control fish of this study, were similar to those obtained in  
previous years in cultured Senegalese sole broodstock at the same facilities (Guzmán et  
al., 2008).  Other studies in Senegalese sole using a single GnRHa injection have also  
reported absence of induced spawning or the occurrence of a few spawns of non-viable  
eggs (Dinis et al., 1999; Agulleiro et al., 2006).  Similarly, in the common sole (Solea  
solea) a single GnRHa injection accelerated ovulation and induced spawning, but did  
not increase fecundity or egg quality compared to Controls (Ramos, 1986).  Although  
the repetitive GnRHa injection method has been used effectively in other species, the  
frequent handling causes significant stress that can have detrimental effects on the  
timing of ovulation, egg quality (Campbell et al., 1992) or broodstock health (Harmin  
and Crim, 1992; Zohar and Mylonas, 2001).  
Treatment with GnRHa implants or microspheres induced daily spawning and  
increased total fecundity by 22- and 15-fold, respectively.  These sustained release  
GnRHa administration methods have been used successfully for the induction of  
spawning in other flatfishes.  For example, treatment with GnRHa implants in Atlantic  
halibut induced ovulation and spawning, and increased relative fecundity slightly  
 ACCEPTED MANUSCRIPT  
compared to untreated fish (Mazorra de Quero et al., 2000).  Similarly, GnRHa implants  
were very effective in stimulating ovulation in turbot (Scophtalmus maximus) (Mugnier  
et al., 2000).  The only study testing the effect of GnRHa microspheres in a flatfish (i.e.,  
the yellowtail flounder) showed similar stimulatory effects to the GnRHa implants,  
inducing multiple ovulations and increasing by ~2-fold egg production compared to  
untreated females (Larsson et al., 1997).  Recently, GnRHa implants have been tried in  
Senegalese sole and showed induction of spawning and a 3-fold increase in relative  
fecundity with a high dose of 50 µg kg-1, but not with a low dose of 5 - 25 µg kg-1  
(Agulleiro et al., 2006).  In the present study, unfortunately, it was not possible to  
ascertain if females implanted with low or a high GnRHa dose contributed equally to  
the total fecundity of the tank.  However, the analysis of individual ovarian biopsies  
taken from GnRHa implanted females revealed that both high-dose and low-dose  
implants caused a similar stimulation of OM, increasing the proportion of post- 
vitellogenic, hydrated and ovulated oocytes, suggesting induction of spawning with  
both doses of implants.  The different results obtained with the GnRHa implants in  
Senegalese sole in our study compared to that of Agulleiro et al. (2006) could be due to  
a different stage of maturity of the females at the moment of treatment, since those  
authors reported absence of post-vitellogenic oocytes at the time of implantation.  These  
data could suggest that the optimal stage for treatment Senegalese sole with GnRHa  
would be when females contain oocytes with diameters of around 550 µm.  This  
optimum oocyte size for initiation of treatment is consistent with previous studies with  
southern flounder and summer flounder (Berlinsky et al., 1996, 1997).  
The ovarian biopsies taken before the hormonal treatments showed oocytes of all  
diameters and stages of development.  This confirmed that ovarian development in  
Senegalese sole is asynchronous (Tyler and Sumpter, 1996), as previously determined  
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in naturally spawning  wild Senegalese  sole  (Rodríguez,  1984)  and  wild-caught  
Senegalese sole maintained in captivity (García-López et al., 2006b).  Treatment with  
both sustained release GnRHa delivery systems induced oocyte growth in all females,  
stimulating maturation of the largest oocyte batches (diameter increase from 550 µm to  
950 µm) and growth of other smaller oocyte batches.  Biopsies taken during the 4-week  
sampling period when spawning occurred almost daily, showed a multimodal oocyte  
diameter frequency distribution, which indicates that Senegalese sole may continuously  
recruit vitellogenic oocytes to maturation, similar to other asynchronous flatfishes such  
as the summer flounder (Watanabe et al., 1998) and greenback flounder (Sun and  
Pankhurst, 2004).  This observation is also consistent with the observation of high  
vitellogenin plasma levels in Senegalese sole females throughout the spawning period  
(Guzmán et al., 2008).  
After  3-4 weeks from treatment with GnRHa implants or microspheres, when  
circulating GnRHa levels were undetectable and spawning was reduced to sporadic  
events of low fecundity, ovarian biopsies revealed accumulation of hydrated and post- 
ovulated oocytes, together with the first signs of oocyte apoptosis.  Considering the  
dates of the experiment, this moment still corresponded to the reported mid-spawning  
period of Senegalese sole and may point to an inhibition of spawning in the absence of  
exogenous GnRHa.  It has been recently observed that the administration of a second  
GnRHa implant after 3 weeks restored daily spawning in 48 h (Guzmán, Mylonas and  
Mañanós, unpublished results).  
In spite of the success in inducing OM, ovulation and spawning by sustained release  
GnRHa treatments, there was a complete failure of fertilization, as observed earlier in  
both GnRHa-induced and spontaneous spawning of cultured Senegalese sole (Agulleiro  
et al., 2006; Guzmán et al., 2008).  One possible explanation for this result would be the  
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absence or alteration of courtship and spawning behaviour of the cultured breeders, a  
critical process for successful reproduction.  In greenback flounder and southern  
flounder, spawning occurs when a male swims close to the female, with genital pores  
together, and lifts the female toward the water surface, at which time eggs and sperm  
are released simultaneously (Smith et al., 1999; Pankhurst and Fitzgibbon, 2006).  In  
common sole, a similar behaviour has been described, in which pairs formed on the tank  
floor swam together towards the water surface where the gamete release took place  
simultaneously (Baynes et al., 1994).  Recent video-recording studies in cultured  
Senegalese sole have shown that in tanks containing GnRHa implanted fish, egg release  
might take place in the absence of any courtship or spawning behaviour (N. Duncan,  
IRTA, Spain, personal communication).  In other flatfishes, such as the flounder  
(Paralichthys orbignyanus) (Bambill et al., 2006) or summer flounder (Watanabe et al.,  
1998; Watanabe and Carroll, 2001), the high variability in egg fertilization success has  
been attributed to a low participation of males in spawning events.  Another factor  
influencing fertilization success could be the inhibition or delayed spawning after  
ovulation, leading to overripening of the eggs (Berlinsky et al., 1996), a process that can  
be especially rapid in warm-water species (Bromage et al., 1994; Zohar and Mylonas,  
2001).  
There was a reduction of the size of the eggs spawned after GnRHa implant or  
microsphere treatment as spawning progressed.  Variations in egg diameter during the  
natural spawning season have been previously described in wild Senegalese sole (Dinis  
et al., 1999), in its congener common sole (Baynes et al., 1993) and in other multiple- 
spawning fishes (Hinckey, 1990; McEvoy and McEvoy, 1991; Kjesbu et al., 1996).  In  
both GnRHa-treated and untreated turbot, egg size decreased concomitantly with egg  
batch number, but without any differences in egg quality (Mugnier et al., 2000).  Also,  
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in  GnRHa-treated  European  sea  bass  a  reduction  in  egg  size  was  observed  in  
consecutive spawns, but without any variations in egg quality (Forniés et al., 2001).  
The underlying reason for decreased egg size along the spawning season in many fishes  
is unclear.  
In conclusion, the present results indicated that cultured Senegalese sole female  
breeders may be induced to undergo OM and spawn spontaneously in a daily rhythm  
after  treatment  with  sustained  administration  of  GnRHa,  through  implants  or  
microspheres.  However, such hormonal treatment is not sufficient to solve the problem  
of complete lack of egg fertilization observed in cultured (F1 generation) broodstock,  
which needs to be investigated further, focusing on breeding behaviour and/or male fish  
function.  
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Table 1.  Classification of Senegalese sole oocyte development based on 
diameter and morphology.  See text for further description.  
Oocyte Stage Range (µm) Mean diameter (µm) 
Primary < 150 110 ±  10 
Cortical alveoli 150 - 250 170 ± 10 
Vitellogenic 250 - 500 440 ± 30 
Post-vitellogenic 500 - 650 590 ± 10 
Hydrated >650 880 ± 90 
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Table 2.  Spawning characteristics of cultured Senegalese sole treated with, saline (Controls, CNT), 
GnRHa injection (INJ), GnRHa implant (IMP) or GnRHa microspheres (MIC).  
Spawning was recorded daily from the day of treatment (April 19th) until the end of the natural 
spawning season (June 21st).  Data are expressed as mean ± SEM. 
 
Nº of spawns 
Spawning period1  
 (days) 
Total relative 
fecundity2 (eggs Kg-1)  
 Daily2 relative 
fecundity (eggs Kg-1)  
 Egg buoyancy (%) 
Egg size3 (µm)  
Hatching success (%) 
CNT INJ 
5 13 
9 32 
9,720 41,960 
1,940 ± 930 3,230 ± 870 
58 ± 10 34 ± 8 
979 ± 3 971 ± 6 
0 0 
IMP MIC 
26 26 
39 37 
208,800 141,880 
8,030 ± 1,760 5,720 ± 1,310 
40 ± 5 27 ± 5 
979 ± 1 978 ± 1 
0 0  
1  Spawning period was the period between the first and last spawn.  
2  Total and daily relative fecundity was calculated based on female biomass.  
3  Egg size is the mean egg diameter of the floating eggs (n=50 eggs per spawn).  
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Figure Legends  
 
Figure 1.  Histological sections of Senegalese sole oocytes obtained from ovarian  
 biopsies. (A) Primary oocytes (PO), oocytes at the cortical alveoli stage (CA) and  
 vitellogenic oocytes (V). (B) Vitellogenic oocyte with the germinal vesicle (GV)  
in a central position, some lipid droplets (L), yolk globules (Y), a clearly defined  
zona radiata (Z) and the follicular layer (F). (C) Post-vitellogenic oocyte with the  
GV migrated to the periphery, and the lipid droplets coalescing into a larger mass.  
The yolk globules are still in a dispersed form. (D) Apoptotic oocyte.  Bars  
represent 100 µm.  
 
Figure 2.  Validation of the GnRHa ELISA for Senegalese sole plasma samples.  The  
 GnRHa standard curve (black circles) shows parallelism with GnRHa spiked  
 Senegalese sole plasma (white circles) and serially diluted plasma from a GnRHa- 
 treated Senegalese sole (black triangles).  Plasma from untreated (GnRHa free)  
 Senegalese sole (black squares) did not exhibit cross-reaction.  
 
Figure 3.  Mean (± SEM) plasma GnRHa levels in female Senegalese sole (n=6) after a  
 single treatment with different GnRHa administration methods: injection (INJ),  
 implant (IMP) or microspheres (MIC).  Each administration method was tested at  
 high (white circles) and low (black circles) GnRHa doses.  Sampling points  
 exhibiting non-detectable GnRHa plasma levels are indicated with ND.  Control  
 fish  were  treated  with  saline  and  had  undetectable  GnRHa  plasma  levels  
 throughout the experiment (not shown).  Letters indicate significant differences  
 (ANOVA, P<0.05) between sampling days within treatment group, indicated in  
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capitals for the high dose and in small letters for the low dose.  The asterisk "*"  
indicates significant differences between doses, within treatment group (P <0.05).  
 
 
Figure 4. Evolution of mean (±SEM) plasma levels of 17ß-estradiol (E2) and 
testosterone (T) in female Senegalese sole (n=6), treated with saline (Control,  
CNT), GnRHa injection (INJ), GnRHa implant (IMP) or GnRHa microspheres  
(MIC).  The GnRHa treatments were applied at high (white circles) and low (black  
circles) doses.  In each graph, different letters indicate significant differences  
(ANOVA, P<0.05) between sampling days within treatment group, indicated in  
capitals for the high dose and in small letters for the low dose.  The asterisk "*"  
indicates significant differences (P<0.05) with respect to the control group for  
each sampling point.  The "#" indicates significant differences (P<0.05) between  
doses, within treatment group.  
 
Figure 5.  Evolution of oocyte diameter frequency distribution in female Senegalese  
 sole treated with saline (Control, CNT), GnRHa injection at 5 or 25 µg kg-1 (INJ 5,  
 INJ 25), GnRHa implant at 10 or 50 µg kg-1 (IMP 10, IMP 50) and GnRHa  
 microspheres at 20 or  100 µg kg-1 (MIC 2, MIC 10).  Each histogram corresponds  
 to the average oocyte frequency distribution from the females of the corresponding  
 group.  The number of biopsied females at each sampling point is indicated in  
 brackets.  The diameter ranges (dotted lines) correspond to different oocyte  
development stages (Table 2, Fig. 1), categorized as primary oocytes (P), cortical alveoli 
(C), vitellogenic (V), post-vitellogenic (M) or hydrated (H).  
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Figure 6.  Daily relative fecundity (egg kg-1 female biomass) of cultured Senegalese  
 sole after a single treatment (day 0) with saline (Control, CNT) or GnRHa  
administrated as an injection (INJ), implant (IMP) or microspheres (MIC).  The 
quantity of buoyant (black bars) and sinking (white bars) eggs was determined for each 
spawning.  
Figure 7.  Correlation of the mean diameter of buoyant eggs (n=50 spawns) with day of  
 spawning of Senegalese sole treated with saline (Control, CNT), GnRHa injection  
 (INJ), GnRHa implant (IMP) or GnRHa microspheres (MIC).  Regression lines  
 were fitted for the entire spawning season of 60 days (dotted line).  For the groups  
 IMP and MIC a second regression line (solid line) was fitted on the 0 to 28 day  
 period, considered to be the period under direct GnRHa influence.  Correlation  
 coefficients (r) and significance of the regressions (P) are indicated in each graph  
 (in bold for the second regression in groups MIC and IMP).  
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